Physician profile
Amanda M Bramham
NPI 1689994014
$394.87
in general payments reported to CMS, 2019-2025
10 companies · $70.92 in 2025
The $70.92 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $96.36 · 2021: $23.71 · 2023: $19.28 · 2025: $70.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $171.88 | 2019-2020 | |
| Lilly USA, LLC | $54.95 | 2019 | |
| Viiv Healthcare Company | $40.42 | 2025 | Apretude |
| Novo Nordisk INC | $23.71 | 2021 | |
| Allergan, INC. | $22.99 | 2020 | |
| Glaxosmithkline, LLC. | $20.28 | 2020 | |
| Abbott Laboratories | $19.28 | 2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $15.72 | 2025 | M-M-R II, Vaxneuvance, Rotateq |
| Exact Sciences Corporation | $14.78 | 2025 | Cologuard Collection Kit |
| Eisai INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bramham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.